ISRCTN16650532已完成未知
The UK Interstitial Lung Disease Long-COVID19 study (UKILD-Long COVID): understanding the burden of interstitial lung disease in long COVID
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 183
研究概览
简要总结
2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34556492/ (added 02/11/2021)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Aged 18 to 99 years old
- •2. Evidence of SARS-CoV-2 infection confirmed by PCR or serology 3 months (+/- 6 weeks) earlier
- •3. Clinical indication for a chest CT scan as per clinician judgment
- •4. Participants who have been identified and consented for the main PHOS-PCOVID study are also eligible to join this study
- •5. Allow inclusion of patients who are receiving up to 10 mg of prednisolone a day
排除标准
- •1. Life-limiting illness within 12 months
- •2. Significant pre-existing lung disease prior to March 2020, which in the investigator’s judgement could make the chest CT scans difficult to interpret
研究者
相似试验
招募中
不适用
The UK Interstitial Lung Disease Long-COVID19 Study (UKILD-Long COVID): Understanding the Burden of Interstitial Lung Disease in Long COVID.SARS-CoV-2 InfectionInterstitial Lung DiseaseNCT05514522Imperial College London2,000
已完成
不适用
RALPMH: Remote assessment of lung disease and impact on physical and mental healthung diseases (COPD, ILD, COVID19)RespiratoryISRCTN16275601South London and Maudsley NHS Foundation Trust60
已完成
不适用
Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19COVID-19SARS-CoV-2 InfectionNCT04410107Federal University of Rio Grande do Sul144
进行中（未招募）
2 期
DEFINE - Evaluating therapies for COVID-19Prevention of lung injury in patients with COVID-19 (SARS-CoV-2 infection)RespiratoryCOVID-19 (SARS-CoV-2 infection)ISRCTN14212905niversity of Edinburgh200
Unknown
不适用
Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19)Covid-19Pulmonary FibrosisNCT04416100Medical University Innsbruck130